1. Home
  2. ALT vs STK Comparison

ALT vs STK Comparison

Compare ALT & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • STK
  • Stock Information
  • Founded
  • ALT 1997
  • STK 2009
  • Country
  • ALT United States
  • STK United States
  • Employees
  • ALT N/A
  • STK N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • STK Investment Managers
  • Sector
  • ALT Health Care
  • STK Finance
  • Exchange
  • ALT Nasdaq
  • STK Nasdaq
  • Market Cap
  • ALT 472.3M
  • STK 545.8M
  • IPO Year
  • ALT N/A
  • STK N/A
  • Fundamental
  • Price
  • ALT $5.32
  • STK $28.33
  • Analyst Decision
  • ALT Strong Buy
  • STK
  • Analyst Count
  • ALT 8
  • STK 0
  • Target Price
  • ALT $21.00
  • STK N/A
  • AVG Volume (30 Days)
  • ALT 3.0M
  • STK 38.2K
  • Earning Date
  • ALT 05-08-2025
  • STK 01-01-0001
  • Dividend Yield
  • ALT N/A
  • STK 6.60%
  • EPS Growth
  • ALT N/A
  • STK N/A
  • EPS
  • ALT N/A
  • STK N/A
  • Revenue
  • ALT $20,000.00
  • STK N/A
  • Revenue This Year
  • ALT N/A
  • STK N/A
  • Revenue Next Year
  • ALT N/A
  • STK N/A
  • P/E Ratio
  • ALT N/A
  • STK N/A
  • Revenue Growth
  • ALT N/A
  • STK N/A
  • 52 Week Low
  • ALT $5.14
  • STK $24.95
  • 52 Week High
  • ALT $11.16
  • STK $34.31
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.42
  • STK 30.88
  • Support Level
  • ALT $5.60
  • STK $29.15
  • Resistance Level
  • ALT $6.16
  • STK $30.58
  • Average True Range (ATR)
  • ALT 0.35
  • STK 0.55
  • MACD
  • ALT 0.01
  • STK 0.05
  • Stochastic Oscillator
  • ALT 17.65
  • STK 8.54

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About STK Columbia Seligman Premium Technology Growth Fund Inc

Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.

Share on Social Networks: